Start with its own history
At 38.61×, 688310.SS is 6.0% below its 6-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
38.61×
6.0% belowthe 6-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 38.61 for every 1 of reported earnings per share.
Annual period-end data · 7 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 38.32× | N/M |
| Dec 31, 2024 | N/M | N/M |
| Dec 31, 2023 | 35.02× | +12.3% |
| Dec 31, 2022 | 31.17× | -48.3% |
| Dec 31, 2021 | 60.28× | +44.8% |
| Dec 31, 2020 | 41.64× | +4.2% |
| Dec 31, 2019 | 39.95× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
688310.SS This stockMaider Medical Industry Equipment Co. Ltd. | 38.61× |
301122.SZCaina Technology Co., Ltd. | 323.59× |
300753.SZJiangsu Apon Medical Technology Co., Ltd. | N/M |
300030.SZImprove Medical Instruments Co., Ltd. | 167.32× |
603987.SSShanghai Kindly Enterprise Development Group Co.,LTD. | 13.06× |
605369.SSZhejiang Gongdong Medical Technology Co.,Ltd. | 47.55× |
688026.SSGuangzhou Jet Bio-Filtration Co., Ltd. | 102.88× |
603309.SSWell Lead Medical Co., Ltd. | 92.55× |
688393.SSGuangzhou LBP Medicine Science & Technology Co., Ltd. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 38.61×, 688310.SS is 6.0% below its 6-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 6 positive peer ratios above is 97.71×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("688310.SS", "PE Ratio", "LQ")Share price 10 ÷ EPS 0.259 = 38.61×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 22, 2026; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.